Skip to main content

Haloperidol

ADVERTISEMENT
Identification
Molecular formula
C21H23ClFNO2
CAS number
52-86-8
IUPAC name
4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
State
State

Haloperidol, at room temperature, is typically in a solid state as a crystalline powder.

Melting point (Celsius)
151.00
Melting point (Kelvin)
424.00
Boiling point (Celsius)
250.00
Boiling point (Kelvin)
523.00
General information
Molecular weight
375.87g/mol
Molar mass
375.8680g/mol
Density
1.4420g/cm3
Appearence

Haloperidol typically appears as a white to faintly yellowish, crystalline powder.

Comment on solubility

Solubility of 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one

This compound exhibits interesting solubility characteristics due to its complex structure. Understanding its solubility behavior is crucial for applications in pharmaceuticals and material sciences. Here are some key points regarding its solubility:

  • Polarity: The presence of polar functional groups such as hydroxyl groups can enhance solubility in polar solvents like water.
  • Hydrophobic Regions: The fluorinated and chlorinated aromatic rings contribute to hydrophobic interactions, which may lead to limited solubility in aqueous environments.
  • Solvent Dependence: Solubility might vary significantly between different solvents. For example, it may dissolve well in organic solvents such as DMSO or ethanol.
  • Temperature Effects: Increased temperature often increases solubility for many compounds, and this may apply to this particular compound as well.

To summarize, while 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one is expected to show some solubility in polar solvents due to its hydroxyl group, its overall solubility will be influenced by the balance between its polar and hydrophobic characteristics. Further experimental data would provide a better understanding of its solubility profile in various environments.

Interesting facts

Interesting Facts about 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one

This compound, often referred to by its systematic name, is particularly notable in the realm of medicinal chemistry due to its intricate structure and potential therapeutic applications. As a member of the class of compounds known as piperidines, it integrates both fluorinated and chloro-substituents, adding to its uniqueness in pharmacological studies.

Key Characteristics:

  • Synthetic Versatility: The presence of multiple functional groups makes this compound an excellent candidate for further synthetic modifications, enabling the exploration of a wide range of derivatives.
  • Biological Activity: Compounds with a similar structure have been researched for their role as potential therapeutic agents in treating various disorders, including those affecting the central nervous system.
  • Fluorination Advantage: The incorporation of fluorine atoms often enhances the metabolic stability of organic molecules, making them more effective as pharmaceuticals.
  • Chloro Influence: The chlorine atom in the structure can influence the compound's electrophilic and nucleophilic properties, potentially modulating its biological interactions.

In the context of drug design, the balance between lipophilicity and hydrophilicity is crucial for determining a compound's bioavailability and efficacy. Thus, researchers study these fluorine and chlorine substitutions closely to optimize the pharmacokinetic profile of such molecules. As one chemist aptly noted, "The magic of medicinal chemistry lies in the details of each atom."
This emphasizes the importance of understanding subtle modifications and how they can significantly affect a compound's functionality and therapeutic potential.

Synonyms
Clofluperol
SEPERIDOL
Clofluperidol
Clofluperolum
Clofluperol [INN:BAN]
UNII-N57F04DIDQ
Clofluperolum [INN-Latin]
CLOFLUPEROL [INN]
DTXSID90146562
Clofluperolum (INN-Latin)
Butyrophenone, 4-[4-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-hydroxypiperidino]-4'-fluoro-
4-(4-(4-Chloro-3-(trifluoromethyl)phenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
DTXCID9069053
Butyrophenone, 4-(4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-4-hydroxypiperidino)-4'-fluoro-
lzfsknppwifmfl-uhfffaoysa-n
10457-91-7
N57F04DIDQ
4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
1-Butanone, 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-
1-BUTANONE, 4-(4-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-4-HYDROXY-1-PIPERIDINYL)-1-(4-FLUOROPHENYL)-
SCHEMBL124937
CHEMBL2111071
BDBM81487
NSC_25293
PDSP1_001635
PDSP2_001619
CAS_10457-91-7
L001194
Q27284569
4-(4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone #